Received: 2 October 2017
Accepted: 26 January 2018
First Online: 7 February 2018
: This ideas presented in this article were developed and discussed over several years based on absolute CVD risk and overdiagnosis research within the STEP and Wiser Healthcare Programs. The release of new guidelines in the US and UK, including the JBS3 suggestion that medication could be prescribed based on heart age, prompted this paper to be written. CB is a behavioural scientist who wrote the paper based on her PhD research investigating CVD risk communication and decision making, including two heart age studies. KB and LI are clinical epidemiologists with expertise in test evaluation and CVD risk models. JJ and KM are psychologists with expertise in shared decision making and risk communication. PG and JD are academic GPs with expertise in evidence-based practice and clinical CVD guidelines.
: The authors declare they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.